http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101958236-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S514-909 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-332 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q19-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-4973 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-343 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61Q19-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-49 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-343 |
| filingDate | 2017-08-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2019-03-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2019-03-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-101958236-B1 |
| titleOfInvention | Pharmaceutical composition for prevention or treatment of obesity comprising licarin a or pharmaceutically acceptable salts thereof as an effective component |
| abstract | The present invention relates to a pharmaceutical composition for preventing or treating obesity containing as an active ingredient licarin A (LA) or a pharmaceutically acceptable salt thereof, and more particularly to a pharmaceutical composition for preventing or treating obesity, Mesenchymal stem cells (MSCs) by browning of adipocytes showing phenotypes such as the production of multilocular lipid droplets, the increase of intracellular mitochondrial content and the number of copies, and the increase of expression of UCP1 (uncoupling protein 1) the present invention relates to a pharmaceutical composition for preventing or treating obesity which can induce differentiation of brown adipocytes or beige adipocytes of white adipocytes into stem cells or white adipocytes. The lyticin A or a pharmaceutically acceptable salt thereof according to the present invention can be applied to a medicine for the treatment of metabolic diseases such as obesity by effectively differentiating white adipocytes into brown or beige adipocytes through browning , And the pharmaceutical industry. |
| priorityDate | 2017-08-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 681.